Candidate Profile definition

Candidate Profile means the form composed by the Agency in which the education, skills and experience of the Candidate is described in detail. The Candidate Profile is subsequently presented to Clients.
Sample 1Sample 2
Candidate Profile means the form that a prospective Member completes and submits to the Club pursuant to Section 2.5 in order to be considered for Membership.
Sample 1Sample 2
Candidate Profile means a report on a member’s knowledge, skills and abilities, criminal history and relevant CPS personnel history.
Sample 1

Examples of Candidate Profile in a sentence

  • Collecting Personal Data and how we collect it As part of the recruiting or engaging process, GPSEA will collect Personal Data that you submit through our application portal in connection with the creation of a Candidate Profile, including your name, address, telephone number, email address, education and employment history, and any Personal Data included on your resume or other documents that you submit.

  • The Candidate Profile domain evaluates the provider's ability to recruit a strong, diverse cohort of candidates and prepare them to teach in the content areas of greatest need.

  • In the rest of this paper, I present some of the arguments against the expansionist model upon the assumed postbiological background.

  • ISR shall decide on all sketches, drawings, reports, recommendations and other matters properly referred to it for decision by Consultant in such reasonable time as not to delay or disrupt the performance by Consultant of the Services under this Agreement.

  • No Overall Performance Ratings This Year Candidate Profile The Candidate Profile domain evaluates the provider's ability to recruit a strong, diverse cohort of candidates and prepare them to teach in the content areas of greatest need.

  • All Candidate Profile forms received will be included in the formal annual meeting notice to be distributed prior to the annual meeting.

  • Throughout the recruitment process, all of our efforts are made to ensure a successful placement of a candidate who fits the Candidate Profile.

  • Candidates meeting the definition of “emerging investment manager” as defined by Illinois State law1 and meeting the screening criteria set forth in this Candidate Profile shall be identified in the screening process as eligible emerging managers.

  • Once you press the LOGIN button, the Candidate Profile Page as shown below will appear: 5.

  • Candidate Profile: 39.50 at 50The candidate has a long-term professional experience related to the subject of Applied Informatics, as well as collaborations with Universities of Greece and Cyprus.


More Definitions of Candidate Profile

Candidate Profile means a Healthcare Professional has completed an application and primary skills assessment. The Candidate has the option to add a secondary specialty skills assessment, & upload a resume / cv, if they have elected any of the prior options they will also be include with the "Candidate Profile" along with and excel data sheet with the Healthcare Professionals pertinent data for easy uploading of data.
Sample 1
Candidate Profile means a passive job candidate’s professional profile and resume information.
Sample 1

Related to Candidate Profile

  • DNA profile means a letter or number code which represents a set of identification characteristics of the non-coding part of an analysed human DNA sample, i.e. the particular molecular structure at the various DNA locations (loci);

  • Dose profile means the dose as a function of position along a line.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • DRS/Profile means the system for the uncertificated registration of ownership of securities pursuant to which ownership of ADSs is maintained on the books of the Depositary without the issuance of a physical certificate and transfer instructions may be given to allow for the automated transfer of ownership between the books of DTC and the Depositary. Ownership of ADSs held in DRS/Profile is evidenced by periodic statements issued by the Depositary to the Holders entitled thereto.

  • Phase I Study means a human clinical trial in any country that would satisfy the requirements of 21 C.F.R. § 312.21(a) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase II Study means a study in humans of the safety, dose ranging or efficacy of a product, as further defined in 21 C.F.R. § 312.21(b) (or the equivalent thereof outside the United States).

  • Product Candidate means each biological and drug candidate, compound or other device or product being developed, labeled, manufactured, marketed, sold and/or distributed by the Company or a Company Subsidiary, or regarding which the Company or a Company has rights, and including any such biological and drug candidate, compound or product that has received Marketing Approval.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • POC (Proof of Concept) means testing the Software for evaluation purposes.

  • Biomarker means a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a specific therapeutic intervention. Biomarkers include, but are not limited to, gene mutations or protein expression.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Phase I Trial means a clinical trial of a Licensed Product in human patients designated as a Phase I Trial and conducted primarily for the purpose of determining the safety of and/or the metabolism and pharmacologic actions of the Licensed Product in humans, as described under 21 CFR § 312.21(a) (as hereafter modified or amended) and any of its foreign equivalents. For purposes of this definition, Phase I Trial shall specifically exclude trials in healthy volunteers.

  • Screening means the process to determine whether the person seeking assistance needs further comprehensive assessment.

  • Pivotal Clinical Trial means a Phase 3 Clinical Trial, or a Phase 2b Clinical Trial for which the applicable Regulatory Authority has determined that the data generated in such Phase 2b Clinical Trial would be sufficient, depending on its outcome, to support the Regulatory Approval for the applicable Licensed Product.

  • Screening Committee means the State level Screening Committee constituted in terms of sub-rule (2) of rule 123 of these rules.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Election campaign means any campaign in support of or in

  • Feasibility Study means the evaluation and analysis of the potential of a project, which aims at supporting the process of decision-making by objectively and rationally uncovering its strengths and weaknesses, opportunities and threats, as well as identifying the resources required to carry it through and ultimately its prospects for success;

  • Step therapy means a protocol or

  • Replacement Candidate means any Candidate Introduced by the Agency to the Client to fill the Engagement following the Introduction of another Candidate whose Engagement either did not commence or was terminated during the first 12 weeks of the Engagement;

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Clinical Study means a Xxxxx 0 Xxxxx, Xxxxx 2 Study, Phase 3 Study, Post-Marketing Study, Supplemental Study or other study (including a non-interventional study) in humans to obtain information regarding the product, including information relating to the safety, tolerability, pharmacological activity, pharmacokinetics, dose ranging or efficacy of the product.